| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.14.10.1586 |
| P953 | full work available at URL | https://www.ahajournals.org/doi/pdf/10.1161/01.ATV.14.10.1586 |
| P698 | PubMed publication ID | 7522547 |
| P2093 | author name string | S. Baker | |
| A. Morrison | |||
| T. Ukena | |||
| D. A. Shewmon | |||
| C. J. Rosen | |||
| J. L. Stock | |||
| E. M. Doyle | |||
| K. M. Heiniluoma | |||
| M. M. Hogue | |||
| V. Weale | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | estrogen | Q277954 |
| tamoxifen | Q412178 | ||
| P304 | page(s) | 1586-1593 | |
| P577 | publication date | 1994-10-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women | |
| P478 | volume | 14 |
| Q58812687 | 17β-Estradiol Potently Suppresses cAMP-induced Insulin-like Growth Factor-I Gene Activation in Primary Rat Osteoblast Cultures |
| Q74148534 | Blood chemistry profiles in menopausal women administered tamoxifen for breast cancer |
| Q74449512 | CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeys |
| Q43767607 | Caloric restriction lowers plasma lipoprotein (a) in male but not female rhesus monkeys |
| Q45260501 | Cardiovascular risks under hormone replacement therapy |
| Q33688752 | Clinical pharmacology of selective estrogen receptor modulators |
| Q80297993 | Complementary medicine for prostate cancer: effects of soy and fat consumption |
| Q34107328 | Complete and selective estrogenic effects on lipids and cardiovascular disease |
| Q46114213 | Did grandma give you heart disease? The new battle against coronary artery disease |
| Q73117194 | Effect of short-term medroxyprogesterone acetate on left ventricular mass: role of insulin-like growth factor-1 |
| Q44624655 | Effect of tamoxifen on fibrinogen, D-dimer, lipid and lipoprotein concentrations in breast cancer patients |
| Q73008386 | Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women |
| Q34199105 | Effects of SERMs on important indicators of cardiovascular health: lipoproteins, hemostatic factors, and endothelial function |
| Q57337242 | Effects of tamoxifen on serum lipid and apolipoprotein levels in postmenopausal patients with breast cancer |
| Q73875036 | Estrogen agonists/antagonists may down-regulate growth hormone signaling in hepatocytes--an explanation for their impact on IGF-I, IGFBP-1, and lipoprotein(a) |
| Q33755845 | Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression |
| Q41517328 | Gonadal hormone substitutes: effects on the cardiovascular system |
| Q33695737 | Hormone replacement therapy |
| Q34675309 | Hormones and heart disease: what we thought, what we have learned, what we still need to know |
| Q51552490 | Hypercholesterolemia and Dyslipidemia. |
| Q51537186 | Hypercholesterolemia and Dyslipidemia: Issues for the Clinician. |
| Q52531799 | Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice? |
| Q40937490 | Lipoprotein(a) in renal disease |
| Q24629580 | Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events |
| Q35754367 | Lipoprotein(a): biology and clinical importance |
| Q44019609 | Multiple Methods for Reduction of Lipoprotein(a). |
| Q34482151 | Postmenopausal hormone replacement therapy as antiatherosclerotic therapy |
| Q33892999 | Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans |
| Q71563616 | Tamoxifen elevates transforming growth factor-beta and suppresses diet-induced formation of lipid lesions in mouse aorta |
| Q45265962 | Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina |
| Q30234123 | The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis |
| Q41689704 | The Potential of SERMs for Reducing the Risk of Coronary Heart Disease |
| Q71808005 | The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein (a) levels in familial hypercholesterolemia |
| Q74525431 | The effect of tamoxifen and transdermal 17beta-estradiol on cerebral arterial vessels: a randomized controlled study |
| Q42647881 | Treatment of symptomatic HyperLp(a)lipoproteinemia with LDL-apheresis: a multicentre study |
| Q44431053 | Treatment of symptomatic hyperLp(a)lipidemia with LDL-apheresis vs. usual care |
| Q35058238 | What is the cardioprotective role of hormone replacement therapy? |
Search more.